BEGIN:VCALENDAR
VERSION:2.0
PRODID:-//Pharma Journalist - ECPv6.16.2//NONSGML v1.0//EN
CALSCALE:GREGORIAN
METHOD:PUBLISH
X-WR-CALNAME:Pharma Journalist
X-ORIGINAL-URL:https://www.pharmajournalist.com
X-WR-CALDESC:Events for Pharma Journalist
REFRESH-INTERVAL;VALUE=DURATION:PT1H
X-Robots-Tag:noindex
X-PUBLISHED-TTL:PT1H
BEGIN:VTIMEZONE
TZID:Asia/Kolkata
BEGIN:STANDARD
TZOFFSETFROM:+0530
TZOFFSETTO:+0530
TZNAME:IST
DTSTART:20210101T000000
END:STANDARD
END:VTIMEZONE
BEGIN:VEVENT
DTSTART;VALUE=DATE:20220421
DTEND;VALUE=DATE:20220701
DTSTAMP:20260516T022202
CREATED:20220425T094247Z
LAST-MODIFIED:20220519T120013Z
UID:33903-1650499200-1656633599@www.pharmajournalist.com
SUMMARY:CPhI & P-MEC China Virtual Expo Connect
DESCRIPTION:This year CPhI & P-MEC China returns as a SMART event\, combining 2 months of online event with a 3-day in-person event to help you connect for an extended period. \n \n“Virtual Expo Connect”\, to be held from 21st April – 30th June 2022\, is the digital extension of the physical CPhI & P-MEC China event that offers an online alternative for global pharma professionals. \nPowered by PharmaSources.com\, Virtual Expo Connect builds the online platform adding valued services and infinite opportunities to connect\, learn\, trade and grow. \nTo know more visit: https://www.pharmasources.com/vec2022
URL:https://www.pharmajournalist.com/event/cphi-p-mec-china-virtual-expo-connect-2/
LOCATION:Online
ORGANIZER;CN="Informa Markets":MAILTO:Yingqi.shi@imsinoexpo.com
END:VEVENT
BEGIN:VEVENT
DTSTART;VALUE=DATE:20220607
DTEND;VALUE=DATE:20220610
DTSTAMP:20260516T022202
CREATED:20220207T092209Z
LAST-MODIFIED:20220207T092209Z
UID:33157-1654560000-1654819199@www.pharmajournalist.com
SUMMARY:2nd Annual Gene Therapy Patient Engagement Summit
DESCRIPTION:Integrate the Patient Voice to Develop Safer & More Effective Gene Therapies That Are Meaningful to Patients \n \nAs investment in gene therapies continues to grow rapidly\, more effectively engaging patients throughout development has become a priority for any company serious about building safer and more meaningful gene therapy programs. \nIn this context\, the 2nd Annual Gene Therapy Patient Engagement Summit will unite patient advocacy and engagement leaders from gene therapy and gene editing drug developers\, patient groups and patients themselves to address the specific challenges of genetic therapy patient engagement\, generating actionable insights through detailed case studies and open\, honest discussions. \nJoin us to hear directly from companies and institutions including Spark Therapeutics\, Ultragenyx\, FDA\, Global Genes\, and CRISPR Therapeutics on key topics including managing expectations across gene therapy development\, navigating patient input on one-time transformative treatments with novel clinical trial designs combined with extensive follow-ups\, and developing educational materials on gene therapy to raise awareness in collaboration with patient advocacy organizations. Leverage their knowledge and experiences to ultimately ensure effective creation and implementation of patient-centric gene therapy programs. \nTo know more visit: https://ter.li/c9d6sy
URL:https://www.pharmajournalist.com/event/2nd-annual-gene-therapy-patient-engagement-summit/
LOCATION:Hyatt Regency Boston\, One Ave. de Lafayette\, Boston\, MA\, 02111\, United States
ORGANIZER;CN="Hanson Wade":MAILTO:info@hansonwade.com
END:VEVENT
END:VCALENDAR